Hepatic Regulation of Fuel Metabolism

  • Catherine Clark
  • Christopher B. Newgard


It has been recognized for more than a century that the liver plays an important role in maintaining metabolic fuel homeostasis. The purpose of this chapter is to summarize mechanisms by which circulating glucose and lipid concentrations are controlled by hepatic metabolic activities.


Glycogen Synthesis Pyruvate Carboxylase Glycogen Phosphorylase Glycogen Metabolism Bifunctional Enzyme 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bell GI, Kayano T, Buse JB et al. Molecular biology of mammalian glucose transporters. Diabetes Care 1990; 13:198–208.PubMedGoogle Scholar
  2. 2.
    Thorens B, Charron MJ, Lodish HF. Molecular physiology of glucose transporters. Diabetes Care 1990; 13:209–18.PubMedGoogle Scholar
  3. 3.
    Thorens B, Sarkar HK, Kaback HR et al. Cloning and functional expression in bacteria of a novel glucose transporter in liver, intestine, kidney, and beta-pancreatic islet cells. Cell 1988; 55:281–90.PubMedGoogle Scholar
  4. 4.
    Johnson JH, Newgard CB, Milburn JL et al. The high Km glucose transporter of islets of langerhans is functionally similar to the low affinity transporter of liver and has an identical primary sequence. J Biol Chem 1990; 265:6548–6551.PubMedGoogle Scholar
  5. 5.
    Guillam MT, Hummler E, Schaerer E et al. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking GLUT-2. Nature Genetics 1997; 17:327–330.PubMedGoogle Scholar
  6. 6.
    Guillam MT, Burcelin R, Thorens B. Normal hepatic glucose production in the absence of GLUT2 reveals an alternative pathway for glucose release from hepatocytes. Proc Natl Acad Sci USA 1998; 95:12317–12321.PubMedGoogle Scholar
  7. 7.
    Burcelin R, del Carmen Munoz M, Guillan MT et al. Liver hyperplasia and paradoxical regulation of glycogen metabolism and glucose-sensitive gene expression in GLUT2-null hepatocytes. Further evidence for the existence of a membrane-based glucose release pathway. J Biol Chem 2000; 275:10930–10936.PubMedGoogle Scholar
  8. 8.
    Matschinsky FM. Regulation of pancreatic beta-cell glucokinase: From basic to therapeutics. Diabetes 2002; 51(Suppl 3):S394–404.PubMedGoogle Scholar
  9. 9.
    Hughes SD, Quaade C, Milburn JL et al. Expression of normal and novel glucokinase mRNAs in anterior pituitary and islet cells. J Biol Chem 1991; 266:4521–4530.PubMedGoogle Scholar
  10. 10.
    Jetton TL, Liang Y, Pettepher CC et al. J Biol Chem 1994; 269:3641–54.PubMedGoogle Scholar
  11. 11.
    Wilson JE. Regulation of mammalian hexokinase activity. In: Beitner R, ed. Regulation of carbohydrate metabolism. Boca Raton: CRC Press, 1984:45–85.Google Scholar
  12. 12.
    Newgard CB. Regulatory role of glucose transport and phosphorylation in pancreatic islet β-cells. Diabetes Reviews 1996; 4:191–205.Google Scholar
  13. 13.
    Malaisse WJ, Malaisse-Lagae F, Davies DR et al. Regulation of glucokinase by a fructose-1-phosphate-sensitive protein in pancreatic islets. Eur J Biochem 1990; 190:539–545.PubMedGoogle Scholar
  14. 14.
    Dethuex M, Vandekerckhove J, Van Schaftingen E. Cloning and sequencing of rat liver cDNAs encoding the regulatory protein of glucokinase. FEBS Lett 1994; 321: 111–115.Google Scholar
  15. 15.
    Iynedjian PB, Ucla C, Mach B. Molecular cloning of glucokinase cDNA: Developmental and dietary regulation of glucokinase mRNA in rat liver. J Biol Chem 1987; 262:6032–38.PubMedGoogle Scholar
  16. 16.
    Andreone TL, Printz RL, Pilkis SJ et al. The amino acid sequence of rat liver glucokinase deduced from cloned cDNA. J Biol Chem 1989; 264:363–69.PubMedGoogle Scholar
  17. 17.
    Iynedjian PB, Pilot P-R, Nouspikel T et al. Differential expression and regulation of the glucokinase gene in liver and islets: Implications for control of glucose homeostasis. Proc Natl Acad Sci USA 1989; 86:7838–42.PubMedGoogle Scholar
  18. 18.
    Toyoda Y, Miwa I, Satake S et al. Nuclear location of the regulatory protein of glucokinase in rat liver and translocation of the regulator to the cytoplasm in response to high glucose. Biochem Biophys Res Comm 1995; 215:467–473.PubMedGoogle Scholar
  19. 19.
    Brown KS, Kalinowski SS, Megill JR et al. Glucokinase regulatory protein may interact with glucokinase in the hepatocyte nucleus. Diabetes 1997; 46:179–186.PubMedGoogle Scholar
  20. 20.
    Shiota C, Coffey J, Grimsby J et al. Nuclear import of hepatic glucokinase depends upon glucokinase regulatory protein, whereas export is due to a nuclear export signal sequence in glucokinase. J Biol Chem 1999; 274:37125–37130.PubMedGoogle Scholar
  21. 21.
    Farrelly D, Brown KS, Tieman A et al. Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: A sequestration mechanism in metabolic regulation. Proc Natl Acad Sci USA 1999; 96:14511–14516.PubMedGoogle Scholar
  22. 22.
    Grimsby J, Coffey JW, Dvorozniak MT et al. Characterization of glucokinase regulatory protein-deficient mice. J Biol Chem 2000; 275:7826–7831.PubMedGoogle Scholar
  23. 23.
    Vehlo G, Frougel P, Clement K et al. Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. Lancet 1992; 340:444–48.Google Scholar
  24. 24.
    Byrne MM, Sturis J, Clement K et al. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest 1994; 93:1122–30.Google Scholar
  25. 25.
    Newgard CB, Matschinsky FM. Substrate Control of Insulin Release. In: Jefferson J, Cherrington A, eds. Handbook of Physiology, Vol II. Oxford Univ. Press, 2001:125–152.Google Scholar
  26. 26.
    Frougel P, Zouali H, Vionnet N et al. Familial hyperglycemia due to mutations in glucokinase. N Engl J Med 1993; 328:697–702.Google Scholar
  27. 27.
    Velho G, Petersen KF, Perseghin G et al. Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest 1996; 98:1755–1761.PubMedGoogle Scholar
  28. 28.
    Gidh-Jain M, Takeda J, Xu LZ et al. Glucokinase mutations associated with noninsulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: Implications for structure/function relationships. Proc Natl Acad Sci USA 1993; 90:1932–36.PubMedGoogle Scholar
  29. 29.
    Liang Y, Kesavan P, Wang L et al. Variable effects of maturity-onset-diabetes of youth (MODY)-associated glucokinase mutations on substrate interactions and stability of the enzyme. Biochem J 1995; 309:167–73.PubMedGoogle Scholar
  30. 30.
    Glaser B, Kesavan P, Heyman M et al. Familial hypoinsulinism caused by an inactivating glucokinase mutation. N Engl J Med 1998; 338:226–240.PubMedGoogle Scholar
  31. 31.
    Grupe A, Hultgren B, Ryan A et al. Transgenic knockouts reveal a critical requirement for pancreatic β-cell glucokinase in maintaining glucose homeostasis. Cell 1995; 83:69–78.PubMedGoogle Scholar
  32. 32.
    Bali D, Svetlanov A, Lee H-W et al. Animal model for maturity-onset diabetes of the young generated by disruption of the mouse glucokinase gene. J Biol Chem 1995; 270:21464–67.PubMedGoogle Scholar
  33. 33.
    Terauchi Y, Sakura H, Yasuda K et al. Pancreatic β-cell-specific targeted disruption of glucokinase gene. J Biol Chem 1995; 270:30253–256.PubMedGoogle Scholar
  34. 34.
    O’Doherty RM, Lehman DL, Seoane J et al. Differential metabolic effects of adenovirus-mediated glucokinase and hexokinase I overexpression in rat primary hepatocytes. J Biol Chem 1996; 271:20524–20530.Google Scholar
  35. 35.
    Seoane J, Gomez-Foix AM, O’Doherty RM et al. Glucose-6-phosphate produced by glucokinase, but not hexokinase is the signal for the activation of hepatic glycogen synthase. J Biol Chem 1996; 271:23756–23760.PubMedGoogle Scholar
  36. 36.
    O’Doherty RM, Lehman DL, Telemaque-Potts S et al. Metabolic impact of glucokinase overexpression in liver: Lowering of blood glucose in fed rats is accompanied by hyperlipidemia. Diabetes 1999; 48:2022–20277.Google Scholar
  37. 37.
    Niswender KD, Shiota M, Postic C et al. Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism. J Biol Chem 1997; 272:22570–22575.PubMedGoogle Scholar
  38. 38.
    Ferre T, Pujol A, Riu E et al. Correction of diabetic alterations by glucokinase. Proc Natl Acad Sci USA 1996; 93:7225–7230.PubMedGoogle Scholar
  39. 39.
    Grimsby J, Sarabu R, Corbett WL et al. Allosteric activators of glucokinase: Potential role in diabetes therapy. Science 2003; 301:370–373.PubMedGoogle Scholar
  40. 40.
    Van Schaftingen E, Hue L, Hers HG. Fructose-2,6-bisphosphate, the probable structure of the glucose and glucagon-sensitive stimulator of phosphofructokinase. Biochem J 1980; 192:897–901.PubMedGoogle Scholar
  41. 41.
    Pilkis SJ, El-Maghrabi MR, Pilkis J et al. Fructose-2,6-bisphosphate. A new activator of phosphofructokinase. J Biol Chem 1981; 256:3171–3174.PubMedGoogle Scholar
  42. 42.
    Uyeda K, Furuya E, Sherry AD. The structure of “activation factor” for phosphofructokinase. J Biol Chem 1981; 256:8679–8684.PubMedGoogle Scholar
  43. 43.
    Murray KJ, El-Maghrabi MR, Kountz PD et al. Amino acid sequence of the phosphorylation site of rat liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. J Biol Chem 1984; 259:7673–7681.PubMedGoogle Scholar
  44. 44.
    Nishimura M, Uyeda K. Purification and characterization of a novel xyulose 5-phosphate-activated protein phosphatase catalyzing dephosphorylation of fructose-6-phosphate, 2 kinase: Fructose-2,6-bisphosphatase. J Biol Chem 1995; 270:26341–26346.PubMedGoogle Scholar
  45. 45.
    Argaud D, Lange AJ, Becker TC et al. Adenovirus-mediated overexpression of liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in gluconeogenic rat hepatoma cells. Paradoxical effect on Fru-2,6-P2 levels. J Biol Chem 1995; 270:24229–24236.PubMedGoogle Scholar
  46. 46.
    Wu C, Okar DA, Newgard CB et al. Overexpression of 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase in mouse liver lowers blood glucose by suppressing hepatic glucose production. J Clin Invest 2001; 107:91–98.PubMedCrossRefGoogle Scholar
  47. 47.
    Wu C, Okar DA, Newgard CB et al. Increasing fructose 2,6-bisphosphate overcomes hepatic insulin resistance of type 2 diabetes. Am J Physiol Endocrinol Metab 2002; 282:E38–45.PubMedGoogle Scholar
  48. 48.
    Yamashita H, Takenoshita M, Sakurai M et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci USA 2001; 98:9116–9121.PubMedGoogle Scholar
  49. 49.
    Kabashima T, Kawaguchi T, Wadzinski BE et al. Xyulose-5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc Natl Acad Sci USA 2003; 100:5107–5112.PubMedGoogle Scholar
  50. 50.
    Engstrom D, Ekman P, Humble E et al. Pyruvate kinase. Enzymes 1987; 18:47–75.Google Scholar
  51. 51.
    Nordlie RC. Metabolic regulation by multifunctional glucose-6-phosphatase. Curr Topic Cell Reg 1974; 8:33–117.Google Scholar
  52. 52.
    Arion WJ, Lange AJ, Walls EH et al. Evidence for the participation of independent translocation for phosphate and glucose 6-phosphate in the microsomal glucose-6-phosphatase system. Interactions of the system with orthophosphate, inorganic pyrophosphate, and carbamyl phosphate. J Biol Chem 1980; 255:10396–10406.PubMedGoogle Scholar
  53. 53.
    Lange AJ, Arion WJ, Beaudet AL. Type 1b glycogen storage disease is caused by a defect in the glucose-6-phosphate translocase of the glucose-6-phosphatase system. J Biol Chem 1980; 255:8381–8384.PubMedGoogle Scholar
  54. 54.
    McGarry JD. Banting lecture 2001: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002; 51:7–18.PubMedGoogle Scholar
  55. 55.
    Tsai CS, Burgett MW, Reed LJ. α-keto acid dehydrogenase complexesXX: A kinetic study of the pyruvate dehydrogenase complex from bovine kidney. J Biol Chem 1973; 248:8348–8352.PubMedGoogle Scholar
  56. 56.
    Denton RM, Randle PJ, Bridges BJ et al. Regulation of mammalian pyruvate dehydrogenase. Mol Cell Biochem 1975; 9:27–53.PubMedGoogle Scholar
  57. 57.
    Sugden MC, Holness MJ. Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs. Am J Physiol 2003; 284:E855–862.Google Scholar
  58. 58.
    Pettit FH, Pelley JW, Reed LJ. Regulation of pyruvate dehydrogenase kinase and phosphatase by acetyl CoA/CoA and NADH/NAD ratios. Biochem Biophys Res Comm 1975; 65:575–582.PubMedGoogle Scholar
  59. 59.
    Ashman LK, Wallace JC, Keech DB. Desensitization of pyruvate carboxylase against acetyl CoA stimulation by chemical modification. Biochem Biophys Res Comm 1975; 51:924–931.Google Scholar
  60. 60.
    Warren GB, Tipton KF. The role of acetyl CoA in the reaction pathway of pig-liver pyruvate carboxylase. Eur J Biochem 1974; 47:549–554.PubMedGoogle Scholar
  61. 61.
    Jin ES, Uyeda K, Kawaguchi T et al. Increased hepatic fructose-2,6-bisphosphate after an oral glucose load does not affect gluconeogenesis. J Biol Chem 2003; 278:28427–28433.PubMedGoogle Scholar
  62. 62.
    Quinn PG, Wong TW, Magnuson MA et al. Identification of the basal and cAMP regulatory elements in the promoter of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 1988; 8:3467–75.PubMedGoogle Scholar
  63. 63.
    Park EA, Roesler WJ, Liu J et al. The role of the CCAAT/enhancer-binding protein in the transcriptional regulation of the gene for phosphoenolpyruvate carboxykinase (GTP). Mol Cell Biol 1990; 10:6264–72.PubMedGoogle Scholar
  64. 64.
    Waltner-Law M, Duong D, Daniels MC et al. Elements of the Glucocorticoid and Retinoic Acid Response Units are Involved in cAMP-mediated Expression of the PEPCK Gene. J Biol Chem 2003; 278;in press.Google Scholar
  65. 65.
    Sasaki K, Cripe TP, Koch SR et al. Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription: Dominant role of insulin. J Biol Chem 1984; 259:15242–51.PubMedGoogle Scholar
  66. 66.
    Duong DT, Waltner-Law M, Sears R et al. Insulin inhibits hepatocellular glucose production by disrupting the association of CBP and RNA polymerase II with the PEPCK gene promoter. J Biol Chem 2002; 277:32234–242.PubMedGoogle Scholar
  67. 67.
    Sasaki K, Granner DK. Regulation of phosphoenolpyruvate carboxykinase gene transcription by insulin and cAMP: Reciprocal actions on initiation and elongation. Proc Nat Acad Sci USA 1988; 85:2954–2958.PubMedGoogle Scholar
  68. 68.
    Liu Z, Barrett EJ, Dalkin AC et al. Effect of acute diabetes on rat hepatic glucose-6-phosphatase activity and its messenger RNA level. Biochem Biophys Res Comm 1994; 205:680–686.PubMedGoogle Scholar
  69. 69.
    Massillon D, Barzilai N, Chen W et al. Glucose regulates in vivo glucose-6-phosphatase gene expression in the liver of diabetic rats. J Biol Chem 1996; 271:9871–9874.PubMedGoogle Scholar
  70. 70.
    Argaud D, Zhang Q, Pan W et al. Regulation of rat liver glucose-6-phosphatase gene expression in different nutritional and hormonal states: Gene structure and 5’-flanking sequence. Diabetes 1996; 45:1563–71.PubMedGoogle Scholar
  71. 71.
    Mithieux G, Vidal H, Zitoun C et al. Glucose-6-phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats. Diabetes 1996; 45:891–896.PubMedGoogle Scholar
  72. 72.
    Argaud D, Kirby TL, Newgard CB et al. Glucose stimulation of glucose-6-phosphatase gene expression in primary hepatocytes and Fao hepatoma cells. Requirement for glucokinase expression. J Biol Chem 1997; 272:12854–12861.PubMedGoogle Scholar
  73. 73.
    ’Brien RM, Streeper RS, Ayala JE et al. Insulin-regulated gene expression. Biochem Soc Trans 2001; 29:552–8.Google Scholar
  74. 74.
    Trinh KY, O’Doherty RM, Anderson P et al. Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats. J Biol Chem 1998; 273:31615–31620.PubMedGoogle Scholar
  75. 75.
    Wu Z, Puigserver P, Andersson U et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999; 98:115–24.PubMedGoogle Scholar
  76. 76.
    Yoon JC, Puigserver P, Chen G et al. Control of hepatic gluconeogenesis through the transcriptional activator PGC-1. Nature 2001; 413:131–8.PubMedGoogle Scholar
  77. 77.
    Ouigserver P, Rhee J, Donovan J et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-lalpha interaction. Nature 2003; 423:550–5.Google Scholar
  78. 78.
    Valera A, Pujol A, Pelegrin M et al. Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop noninsulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1994; 91:9151–4.PubMedGoogle Scholar
  79. 79.
    She P, Shiota M, Shelton KD et al. Phosphoenolpyruvate carboxykinase is necessary for integration of hepatic energy metabolism. Mol Cell Biol 2000; 20:6508–17.PubMedGoogle Scholar
  80. 80.
    She P, Burgess SC, Shiota M et al. Mechanisms by which liver-specific PEPCK knockout mice preserve euglycemia during starvation. Diabetes 2003; 52:1649–54.PubMedGoogle Scholar
  81. 81.
    Seoane J, Trinh K, O’Doherty RM et al. Metabolic impact of adenovirus-mediated overexpression of the glucose-6-phosphatase catalytic subunit in primary hepatocytes. J Biol Chem 1997; 272:26972–26977.PubMedGoogle Scholar
  82. 82.
    An J, Li Y, van De Werve G et al. Overexpression of the P46 (T1) translocase component of the glucose-6-phosphatase complex in hepatocytes impairs glycogen accumulation via hydrolysis of glucose 1-phosphate. J Biol Chem 2001; 276:10722–10779.PubMedGoogle Scholar
  83. 83.
    Sutherland EW, Robinson GA. The role of cyclic AMP in the control of carbohydrate metabolism. Diabetes 1969; 18:797–819.PubMedGoogle Scholar
  84. 84.
    Newgard CB, Hwang PK, Fletterick RJ. The family of glycogen phosphorylases: Structure and function. CRC critical reviews in biochemistry and molecular biology 1989; 24:69–99.PubMedGoogle Scholar
  85. 85.
    Lawrence Jr JC, Roach PJ. New insights into the role and mechanism of glycogen synthase activation by insulin. Diabetes 1997; 46:541–7.PubMedGoogle Scholar
  86. 86.
    McGarry JD, Kuwajima M, Newgard CB et al. From dietary glucose to liver glycogen—The full circle round. Annual Review of Nutrition 1986; 7:51–73.Google Scholar
  87. 87.
    Ferrer JC, Favre C, Gomis RR et al. Control of glycogen deposition. FEBS Lett 2003; 546:127–32.PubMedGoogle Scholar
  88. 88.
    Frame S, Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J 2001; 359:1–16.PubMedGoogle Scholar
  89. 89.
    Newgard CB, Brady MJ, O’Doherty RM et al. Organizing glucose disposal: Emerging roles of the glycogen targeting subunits of protein phosphatase-1. Diabetes 2000; 49:1967–1977.PubMedGoogle Scholar
  90. 90.
    Tang PM, Bondor JA, Swiderek KM et al. Molecular cloning and expression of the regulatory (RG1) subunit of the glycogen-associated protein phosphatase. J Biol Chem 1991; 266:15782–15789.PubMedGoogle Scholar
  91. 91.
    Chen YH, Hansen L, Chen MX et al. Sequence of the human glycogen-associated regulatory subunit of type 1 protein phosphatase and analysis of its coding region and mRNA level in muscle from patients with NIDDM. Diabetes 1994; 43:1234–1241.PubMedGoogle Scholar
  92. 92.
    Doherty MJ, Moorhead G, Morrice N et al. Amino acid sequence and expression of the hepatic glycogen-binding (GL)-subunit of protein phosphatase-1. FEBS Lett 1995; 375:294–298.PubMedGoogle Scholar
  93. 93.
    Printen JA, Brady MJ, Saltiel AR. PTG, a protein phosphatase 1-binding protein with a role in glycogen metabolism. Science 1997; 275:1475–1478.PubMedGoogle Scholar
  94. 94.
    Doherty MJ, Young PR, Cohen PT. Amino acid sequence of a novel protein phosphatase 1 binding protein (R5) which is related to the liver-and muscle-specific glycogen binding subunits of protein phosphatase 1. FEBS Lett 1996; 399:339–343.PubMedGoogle Scholar
  95. 95.
    Armstrong CG, Browne GJ, Cohen P et al. PPP1R6, a novel member of the family of glycogen-targetting subunits of protein phosphatase 1. FEBS Lett 1997; 418:210–214.PubMedGoogle Scholar
  96. 96.
    Berman HK, O’Doherty RM, Anderson P et al. Overexpression of protein targeting to glycogen (PTG) in rat hepatocytes causes profound activation of glycogen synthesis independent of normal hormone-and substrate-mediated regulatory mechanisms. J Biol Chem 1998; 273:26421–26425.PubMedGoogle Scholar
  97. 97.
    Gasa R, Jensen P-B, Berman H et al. Differential regulatory and metabolic properties of glycogen targeting subunits (PTG, GL, GM) expressed in hepatocytes. J Biol Chem 2000; 275:26396–26403.PubMedGoogle Scholar
  98. 98.
    Gasa R, Clark C, Yang R et al. Reversal of diet-induced glucose intolerance by hepatic expression of a variant glycogen-targeting subunit of protein phosphatase-1. J Biol Chem 2002; 277:1524–1530.PubMedGoogle Scholar
  99. 99.
    O’Doherty RM, Jensen PB, Anderson P et al. Activation of direct and indirect pathways of glycogen synthesis by hepatic overexpression of protein targeting to glycogen. J Clin Invest 2000; 105:479–488.Google Scholar
  100. 100.
    Yang R, Newgard CB. Hepatic expression of a targeting subunit of protein phosphatase-1 in streptozotocin-diabetic rats reverses hyperglycemia and hyperphagia despite depressed glucokinase expression. J Biol Chem 2003; 278:23418–23425.PubMedGoogle Scholar
  101. 101.
    Martin WH, Hoover DJ, Armento SJ et al. Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo. Proc Natl Acad Sci USA 1998; 95:1776–1781.PubMedGoogle Scholar
  102. 102.
    Treadway JL, Mendys P, Hoover DJ. Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus. Expert Opin Investig Drugs 2001; 10:439–354.PubMedGoogle Scholar
  103. 103.
    Coghlan MP, Culbert AA, Cross DA et al. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol 2000; 7:793–803.PubMedGoogle Scholar
  104. 104.
    Cline GW, Johnson K, Regittnig W et al. Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. Diabetes 2002; 51:2903–2910.PubMedGoogle Scholar
  105. 105.
    Abel ED, Peroni O, Kim JK et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 2001; 409:729–733.PubMedGoogle Scholar
  106. 106.
    An J, Muoio DM, Shiota M et al. Hepatic expression of malonyl CoA decarboxylase reverses muscle, liver, and whole animal insulin resistance. Nat Med 2004; 10(3):268–274.PubMedGoogle Scholar
  107. 107.
    Ntambi JM, Miyazaki M, Dobrzyn A. Regulation of stearoyl-CoA desaturase expression. Lipids 2004; 29:1061–1065.Google Scholar
  108. 108.
    Kim JK, Fillmore JJ, Chen Y et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci USA 2001; 98:7522–7527.PubMedGoogle Scholar
  109. 109.
    Moore MC, Rossetti L, Pagliassotti MJ et al. Neural and pancreatic influences on net hepatic glucose uptake and glycogen synthesis. Am J Physiol 1996; 271:E215–E222.PubMedGoogle Scholar
  110. 110.
    Burcelin R, Crivelli V, Perrin C et al. GLUT4, AMP kinase, but not the insulin receptor, are required for hepatoportal glucose sensor-stimulated muscle glucose utilization. J Clin Invest 2003; 111:1555–1562.PubMedGoogle Scholar
  111. 111.
    Burcelin R, Dolci W, Thorens B. Glucose sensing by the hepatoportal sensor is GLUT2-dependent. In vivo analysis of GLUT2-null mice. Diabetes 2000; 49:1643–1648.PubMedGoogle Scholar
  112. 112.
    Lam TKT, Pocai A, Gutierrez-Juarez R et al. Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nature Medicine 2005; (online ahead of print).Google Scholar
  113. 113.
    Boden G, Chen X, Capulong E et al. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. Diabetes 2001; 50:810–816.PubMedGoogle Scholar
  114. 114.
    Newgard CB. Regulation of glucose metabolism in the liver. In: DeFronzo RA, Ferrannini E, Keen H et al. International Textbook of Diabetes. 3rd ed. John Wiley and Sons, 2004:253–276.Google Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2007

Authors and Affiliations

  • Catherine Clark
  • Christopher B. Newgard
    • 1
  1. 1.Duke Independence Park FacilitySarah W. Stedman Nutrition and Metabolism CenterDurhamUSA

Personalised recommendations